Cluster headache: a single tertiary center study

Zeynep Tuncer Issı1, Nurcan Akbulut2, Vesile Öztürk3

  • 1Department of Pain Management, Sakarya Research and Training Hospital, Sakarya, Turkey.

Neurological Research
|November 16, 2021
PubMed

Insights

This study describes cluster headache (CH) patient characteristics in Turkey, revealing similarities and differences with global data. Findings highlight potential regional variations in CH presentation and treatment.

Area of Science:

  • Neurology
  • Clinical Neuroscience
  • Epidemiology

Background:

  • Cluster headache (CH) is a debilitating neurological disorder with documented clinical features and management strategies globally.
  • However, limited clinical data from Turkey hinders a comprehensive understanding of regional variations in CH.

Purpose of the Study:

  • To characterize the clinical features, demographics, and treatment approaches of cluster headache patients in Turkey.
  • To compare these findings with existing data from other global regions.

Main Methods:

  • A cross-sectional retrospective study was conducted.
  • Data from 114 cluster headache patients diagnosed and referred to Dokuz Eylül University Headache Clinic between 1991 and 2018 were analyzed.

Main Results:

  • The study included 114 patients (90 males, 24 females) with a mean age at onset of 31.68 years.
  • Episodic cluster headache (ECH) was more prevalent (78.18%) than chronic cluster headache (CCH) (21.82%).
  • The most common location was orbitotemporal, with lacrimation as the most frequent accompanying symptom. Verapamil was the most common prophylactic treatment.

Conclusions:

  • Turkish cluster headache patients exhibit some clinical features similar to those in Europe, America, and Asia, but also notable differences.
  • These findings suggest regional variations in cluster headache presentation.
  • Further research from diverse countries is essential to objectively elucidate these clinical differences.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...